Supplementary Figures 1 - 6 from &lt;i&gt;In Silico&lt;/i&gt; Screening Reveals Structurally Diverse, Nanomolar Inhibitors of NQO2 That Are Functionally Active in Cells and Can Modulate NF-κB Signaling